Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
AFIB Acutus Medical
1.790+0.040+2.29%
Close
02/03 16:00 ET
1.7900.0000.00%
Post Mkt Price 02/03 16:08 ET
High
1.850
Open
1.750
Turnover
324.27K
Low
1.670
Pre Close
1.750
Volume
181.36K
Post-Market
5D
1D
1W
1M
1Q
1Y
Price Forecast
News
Comment
Acutus Medical Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Acutus Medical, Inc. (NASDAQ:AFIB) Sees Large Decline in Short Interest
Acutus Medical, Inc. (NASDAQ:AFIB – Get Rating) was the recipient of a significant decline in short interest during the month of December. As of December 30th, there was short interest totalling 899,
APPH, SLRX and ARBK Among Mid-day Movers
Acutus Medical Says Received Letter From Nasdaq Notifying Co. That It Had Regained Compliance With Minimum Bid Price Requirement
Acutus Medical Says Received Letter From Nasdaq Notifying Co. That It Had Regained Compliance With Minimum Bid Price Requirement
Acutus Medical Picks New CFO From Within, Announces 2023 Guidance
Acutus Medical Sees Q4 Revenue $4.7M-$4.9M Above Estimates; Appoints Takeo Mukai as CFO
Acutus Medical Sees Q4 Sales $4.7M-$4.9M Vs. $4.15M Est., FY22 Sales $16.1M-$16.3M Vs. $15.7M Est.
Acutus Medical Sees Q4 Sales $4.7M-$4.9M Vs. $4.15M Est., FY22 Sales $16.1M-$16.3M Vs. $15.7M Est.
Acutus Medical Sees Cash Burn Declining 25%-30% Vs 3Q 2022 and 35%-40% Vs 4Q 2021
Acutus Medical Sees FY22 Rev $16.1M-$16.3M >AFIB
Acutus Medical: Mukai Was Most Recently Serving as Interim CFO >AFIB
Company Overview
More
Acutus Medical, Inc. engages in the development of medical devices and electrophy equipment. It creates electrophysiological mapping systems for the treatment of cardiac arrhythmias, such as atrial fibrillation, and ventricular tachycardia. The company was founded by Randell L. Werneth and Christoph Scharf in 2011 and is headquartered in Carlsbad, CA.
CEO： Mr. David H. Roman
Market： NASDAQ
Listing Date： 08/06/2020
Paper Trade
More
Hot List
TradeSearchNews
SymbolLatest price%Chg
Loading...
Watchlist
No Stock Yet